版本:
中国

BRIEF-Vbi vaccines provides update on its congenital CMV early-stage study

May 2 VBI Vaccines Inc-

* VBI Vaccines provides update on its congenital cmv phase i clinical study

* VBI Vaccines Inc - no safety signals have been detected, suggesting vbi's cmv vaccine candidate is safe and well-tolerated

* VBI Vaccines Inc - an interim safety and immunogenicity report, is expected mid-year 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐